Wuhan Easy Diagnosis Biomedicine Co.,Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 372.4 million compared to CNY 2,487.21 million a year ago. Revenue was CNY 372.4 million compared to CNY 2,487.21 million a year ago.

Net income was CNY 75.45 million compared to CNY 1,389.04 million a year ago. Basic earnings per share from continuing operations was CNY 0.3289 compared to CNY 6.0872 a year ago. Diluted earnings per share from continuing operations was CNY 0.3221 compared to CNY 6.047 a year ago.